For women with dense breasts, MRI detects significantly more cancers than ultrasound. In the first round of supplemental screening after mammography, MRI finds roughly three times more cancers than mammography alone, with a detection rate of 16.6 per 1,000 exams. Ultrasound improves on mammography too, but not by nearly as much. The tradeoff: MRI costs more, takes longer, and isn’t always covered by insurance.
Which option makes sense for you depends on your breast density category, your overall cancer risk, and what’s realistically accessible. Here’s what the evidence shows.
Why Dense Breasts Need More Than a Mammogram
Breast density is classified into four categories. Categories A and B describe breasts that are mostly fatty tissue, where mammograms work well on their own. Categories C (heterogeneously dense) and D (extremely dense) are where mammography starts to struggle. Dense tissue appears white on a mammogram, and so do tumors, which means cancers can hide behind the dense tissue like a snowball in a snowstorm.
Nearly half of women who get mammograms fall into categories C or D. For these women, a normal mammogram is less reassuring than it sounds, because small cancers can go undetected. That’s why supplemental screening with ultrasound or MRI exists: to catch what the mammogram misses.
How Each Technology Works
Ultrasound uses sound waves that bounce off tissue. Dense tissue and tumors reflect sound differently, so ultrasound can distinguish solid masses from fluid-filled cysts and pick up cancers that blend into dense tissue on a mammogram. It’s also good at detecting blood flow patterns inside a mass, which helps determine whether a lump is concerning.
MRI uses magnetic fields and radio waves to create highly detailed cross-sectional images of breast tissue. It provides superior soft tissue contrast compared to virtually every other imaging method. During a breast MRI, you receive an injection of contrast dye, which highlights areas of increased blood flow. Cancers tend to grow new blood vessels to feed themselves, so they light up on contrast-enhanced MRI in ways that normal tissue does not. MRI can also detect characteristics like restricted water movement within cells, a hallmark of many malignant tumors.
MRI Finds More Cancers
The detection gap between these two technologies is substantial. Supplemental breast MRI after a normal mammogram catches about 16.6 cancers per 1,000 exams in the first screening round. In subsequent rounds, the rate drops to 6.8 per 1,000, which is expected because the first scan catches cancers that have been accumulating undetected.
Ultrasound also finds additional cancers beyond what mammography catches, but at a lower rate. Its specificity ranges from 42% to 82%, meaning it produces a fair number of false alarms. When ultrasound flags something suspicious, there’s a reasonable chance it turns out to be benign after a biopsy. MRI has its own false-positive problem, but its overall sensitivity, its ability to catch real cancers, is higher than ultrasound’s across the board.
Both handheld ultrasound and automated whole-breast ultrasound systems perform comparably to each other, so the choice between those two versions doesn’t meaningfully change your results.
What the Guidelines Recommend
The American College of Radiology bases its recommendations on two factors: how dense your breasts are and your lifetime cancer risk level.
For women with extremely dense breasts (category D) at average risk, MRI is listed as “usually appropriate,” meaning it’s the recommended supplemental tool. Ultrasound is rated “may be appropriate,” a step below. For heterogeneously dense breasts (category C) at average risk, both MRI and ultrasound fall into the “may be appropriate” category.
Risk level shifts the equation. If your lifetime risk is intermediate or high (20% or above, based on family history, genetics, or other factors), MRI becomes “usually appropriate” regardless of whether your breasts are heterogeneously dense or extremely dense. Ultrasound stays at “may be appropriate” across all risk and density combinations, positioning it as a secondary option when MRI isn’t feasible.
Across all scenarios, 3D mammography (tomosynthesis) remains the foundation. Ultrasound and MRI are supplements to mammography, not replacements.
Abbreviated MRI: A Faster, Cheaper Middle Ground
Standard breast MRI takes about 17 minutes of scan time, requires an IV contrast injection, and can cost over $1,000 out of pocket. That’s prompted the development of abbreviated MRI protocols, which compress the scan to roughly three minutes while maintaining the same diagnostic accuracy.
Research from Memorial Sloan Kettering found that abbreviated MRI detected the same cancers as the full protocol in a study of over 600 exams. Radiologists could interpret the abbreviated images in about 28 seconds, compared to two to four minutes for a standard mammogram. The shorter scan translates to lower costs, potentially making MRI screening accessible to more women.
The ACR now lists abbreviated MRI as “usually appropriate” in the same situations where full MRI gets that rating. It’s increasingly available at imaging centers and represents the most promising option for closing the gap between ultrasound’s affordability and full MRI’s detection power.
Cost and Insurance Coverage
This is where the practical reality gets complicated. Ultrasound is significantly cheaper than MRI. A screening breast ultrasound typically runs a few hundred dollars, while a full breast MRI can cost several times that amount.
Many states now have breast density notification laws that require facilities to inform you if you have dense breasts. However, follow-up imaging for dense breasts is not currently required to be covered by insurers as a preventive service. That means even if your doctor recommends supplemental MRI, you could face significant out-of-pocket costs depending on your plan. Some insurers cover MRI only for women who meet specific high-risk criteria, while ultrasound coverage tends to be somewhat easier to obtain.
If MRI is the better test but you can’t access it due to cost, supplemental ultrasound still catches cancers that mammography alone would miss. It’s a meaningful improvement over no supplemental screening at all.
Choosing Based on Your Situation
If you have extremely dense breasts or elevated cancer risk, MRI (or abbreviated MRI) is the stronger choice whenever it’s available and affordable. It simply finds more cancers, and the ones it catches tend to be smaller and earlier stage.
If you have heterogeneously dense breasts and average risk, the decision is less clear-cut. Both ultrasound and MRI are reasonable options. Ultrasound is easier to access, requires no IV injection, takes less time, and costs less. MRI detects more, but the incremental benefit narrows when your overall risk is lower.
If cost or access rules out MRI entirely, ultrasound is a solid alternative. It’s widely available, painless, and catches cancers that mammograms miss in dense tissue. The best supplemental screening is the one you actually get.